日期 | 时间 | 会场 | Session | 角色 | 讲题 |
---|---|---|---|---|---|
2024-11-16 | 15:10-15:30 | 西安国际会展中心会议楼二层多功能厅C |
Session 1 |
讲者 | CD64+ fibroblast-targeted vilanterol and a STING agonist augment CLDN18.2 BiTEs efficacy against pancreatic cancer by reducing desmoplasia and enriching stem-like CD8+ T cells |